Matches in SemOpenAlex for { <https://semopenalex.org/work/W4285492259> ?p ?o ?g. }
- W4285492259 endingPage "1790" @default.
- W4285492259 startingPage "1773" @default.
- W4285492259 abstract "Abstract Drug resistance is a key factor in the treatment failure of acute myeloid leukemia (AML). Nuclear factor E2-related factor 2 (Nrf2) plays a crucial role in tumor chemotherapy resistance. However, the potential mechanism of Nrf2 regulating DNA mismatch repair (MMR) pathway to mediate gene-instability drug resistance in AML is still unclear. Here, it was found that Nrf2 expression was closely related to the disease progression of AML as well as highly expressed in AML patients with poor prognostic gene mutations. Meanwhile, it was also found that the expression of Nrf2 was significantly negatively correlated with DNA MMR gene replication factor C4 (RFC4) in AML. CHIP analysis combined with luciferase reporter gene results further showed that Nrf2 may inhibit the expression of RFC4 by its interaction with the RFC4 promoter. In vitro and vivo experiments showed that the overexpression of Nrf2 decreased the killing effect of chemotherapy drug cytarabine (Ara-C) on leukemia cells and inhibited the expression of RFC4. Mechanistically, The result that Nrf2-RFC4 axis mediated AML genetic instability drug resistance might be received by activating the JNK/NF-κB signaling pathway. Taken together, these findings may provide a new idea for improving AML drug resistance." @default.
- W4285492259 created "2022-07-15" @default.
- W4285492259 creator A5005929608 @default.
- W4285492259 creator A5018881082 @default.
- W4285492259 creator A5036361052 @default.
- W4285492259 creator A5036378520 @default.
- W4285492259 creator A5040558103 @default.
- W4285492259 creator A5041658242 @default.
- W4285492259 creator A5069377239 @default.
- W4285492259 creator A5070390666 @default.
- W4285492259 creator A5075075087 @default.
- W4285492259 date "2022-07-15" @default.
- W4285492259 modified "2023-10-10" @default.
- W4285492259 title "Nrf2 overexpression increases the resistance of acute myeloid leukemia to cytarabine by inhibiting replication factor C4" @default.
- W4285492259 cites W1967881866 @default.
- W4285492259 cites W1974958104 @default.
- W4285492259 cites W2007115735 @default.
- W4285492259 cites W2023367198 @default.
- W4285492259 cites W2042243713 @default.
- W4285492259 cites W2043281296 @default.
- W4285492259 cites W2044088883 @default.
- W4285492259 cites W2050345519 @default.
- W4285492259 cites W2051486692 @default.
- W4285492259 cites W2055196208 @default.
- W4285492259 cites W2056622279 @default.
- W4285492259 cites W2059705009 @default.
- W4285492259 cites W2063953032 @default.
- W4285492259 cites W2064611221 @default.
- W4285492259 cites W2067466498 @default.
- W4285492259 cites W2070569107 @default.
- W4285492259 cites W2092286165 @default.
- W4285492259 cites W2093855538 @default.
- W4285492259 cites W2119088658 @default.
- W4285492259 cites W2138271341 @default.
- W4285492259 cites W2142449962 @default.
- W4285492259 cites W2160618318 @default.
- W4285492259 cites W2163005196 @default.
- W4285492259 cites W2165167356 @default.
- W4285492259 cites W2165837717 @default.
- W4285492259 cites W2233124939 @default.
- W4285492259 cites W2509946779 @default.
- W4285492259 cites W2514466499 @default.
- W4285492259 cites W2548618596 @default.
- W4285492259 cites W2590604244 @default.
- W4285492259 cites W2593230508 @default.
- W4285492259 cites W2606020928 @default.
- W4285492259 cites W2615959728 @default.
- W4285492259 cites W2616559291 @default.
- W4285492259 cites W2742281710 @default.
- W4285492259 cites W2767322731 @default.
- W4285492259 cites W2790803800 @default.
- W4285492259 cites W2794139372 @default.
- W4285492259 cites W2801988573 @default.
- W4285492259 cites W2884473318 @default.
- W4285492259 cites W2887033855 @default.
- W4285492259 cites W2893024014 @default.
- W4285492259 cites W2895658142 @default.
- W4285492259 cites W2896514449 @default.
- W4285492259 cites W2923315793 @default.
- W4285492259 cites W2937556309 @default.
- W4285492259 cites W2948948888 @default.
- W4285492259 cites W2989544483 @default.
- W4285492259 cites W3015746024 @default.
- W4285492259 cites W3020593143 @default.
- W4285492259 cites W3049436326 @default.
- W4285492259 cites W3092165410 @default.
- W4285492259 cites W3104374082 @default.
- W4285492259 cites W3109540700 @default.
- W4285492259 cites W3119935843 @default.
- W4285492259 cites W3128514875 @default.
- W4285492259 cites W3130903278 @default.
- W4285492259 cites W3158922343 @default.
- W4285492259 cites W3164477864 @default.
- W4285492259 cites W3177175576 @default.
- W4285492259 cites W4231346141 @default.
- W4285492259 doi "https://doi.org/10.1038/s41417-022-00501-1" @default.
- W4285492259 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35840666" @default.
- W4285492259 hasPublicationYear "2022" @default.
- W4285492259 type Work @default.
- W4285492259 citedByCount "4" @default.
- W4285492259 countsByYear W42854922592023 @default.
- W4285492259 crossrefType "journal-article" @default.
- W4285492259 hasAuthorship W4285492259A5005929608 @default.
- W4285492259 hasAuthorship W4285492259A5018881082 @default.
- W4285492259 hasAuthorship W4285492259A5036361052 @default.
- W4285492259 hasAuthorship W4285492259A5036378520 @default.
- W4285492259 hasAuthorship W4285492259A5040558103 @default.
- W4285492259 hasAuthorship W4285492259A5041658242 @default.
- W4285492259 hasAuthorship W4285492259A5069377239 @default.
- W4285492259 hasAuthorship W4285492259A5070390666 @default.
- W4285492259 hasAuthorship W4285492259A5075075087 @default.
- W4285492259 hasBestOaLocation W42854922591 @default.
- W4285492259 hasConcept C104317684 @default.
- W4285492259 hasConcept C114851261 @default.
- W4285492259 hasConcept C203014093 @default.
- W4285492259 hasConcept C207001950 @default.
- W4285492259 hasConcept C2776694085 @default.
- W4285492259 hasConcept C2778041864 @default.